| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3848541 | American Journal of Kidney Diseases | 2013 | 10 Pages |
Abstract
In the period after PPS implementation, IV vitamin D use decreased, use of oral therapies for metabolic bone disease increased, erythropoiesis-stimulating agent use and hemoglobin levels decreased, and transfusion rates increased numerically.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Steven M. MD, MSCE, Keri L. PhD, John M. MD, Matthew PharmD, Peter J. ScD, Grace S. DrPH, Margarita MD, Susan MD, Brian D. DSc, Robert J. MD,